Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients-Reference-Cited by-同舟云学术

Effect of gender and ITPA polymorphisms on ribavirin-induced anemia in chronic hepatitis C patients

Published:2013-11 Issue:5 Volume:59 Page:964-971
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Scherzer Thomas-Matthias,Stättermayer Albert Friedrich,Stauber Rudolf,Maieron Andreas,Strasser Michael,Laferl Hermann,Schwarzer Remy,Datz Christian,Rutter Karoline,Beinhardt Sandra,Steindl-Munda Petra,Hofer Harald,Ferenci Peter

Publisher

Elsevier BV

Subject

Hepatology

Reference38 articles.

1. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

2. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial;Kwo;Lancet,2010

3. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection;Hézode;N Engl J Med,2009

4. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage;De Franceschi;Hepatology,2000

5. Inosinetriphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR;Thompson;Hepatology,2011

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin‐induced anaemia and outcome in hepatitis C virus‐infected patients: A meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2020-07-31

2. A Review on Clinical, Pathophysiological, and Diagnostic Hematological Features in Children With Liver Cirrhosis;International Journal of Basic Science in Medicine;2019-09-30

3. Inosine triphosphate pyrophosphatase polymorphisms are predictors of anemia in Chinese patients with chronic hepatitis C during therapy with ribavirin and interferon;Journal of Gastroenterology and Hepatology;2019-08-23

4. Tolerability of Erythrocyte Ribavirin Triphosphate Concentrations Depends on the ITPA Genotype;Therapeutic Drug Monitoring;2019-08

5. DHEA prevents ribavirin-induced anemia via inhibition of glucose-6-phosphate dehydrogenase;Antiviral Research;2017-10